AMCP Corporate Member Spotlight: EVERSANA

Jeff LaVaute

AMCP News & Views recently caught up with Jeff LaVaute, managing director of strategy for EVERSANA ENGAGE to learn about his company and gain insights on becoming an AMCP Corporate Member. 

As you considered becoming a Corporate Member, what tipped the scales?  

Becoming an AMCP corporate member was a no-brainer for us. We have been a proud member of AMCP for several years. We officially joined as EVERSANA in 2019, just months after the company first launched following the initial merger of six leaders in the life sciences industry. 

Our market access team, based primarily in New Jersey and New York at that time, had worked with   AMCP for some time and saw the many benefits that membership brings to our employees and clients. We were able to take advantage of educational opportunities as well as other resources that really helped bring immense value to a variety of stakeholders. 

As our work evolved over the past few years, we’ve had opportunities to speak at conferences and other AMCP-sponsored events, and it’s been a great fit for EVERSANA’s growth and evolution. 

During COVID, we worked closely with the AMCP team to successfully convert live Pre-approval Information Exchange (PIE) and Product Theater sessions into virtual engagements. These helped to provide the continued great educational work from AMCP allowed our many clients to engage payer stakeholders on the most relevant topics of the time. 

What is your strategy and anticipated innovations for 2022?  

Innovation is the lifeblood of everything we do at EVERSANA.  

As a company, we’re built to bring an innovative, new approach to the life sciences and pharmaceutical industries that will drive greater commercial success for our clients and ultimately help more patients receive access to life-impacting therapies. 

Since 2019, we’ve added several important pieces to the EVERSANA family, including a global value & evidence team and a robust data and analytics team and platform that today is unmatched in terms of its depth and quality of insights. Data-driven decision-making is vital in today’s marketplace, and our platform, connected to everything we do at EVERSANA, really sets our customers up for immediate, informed success. 

Additionally, in the past six months, we have added the leading digital and creative agency team from Intouch Group to EVERSANA, strengthening our position and ability to help clients deliver next-generation digital campaigns that connect patients with messaging they need at the right time and right place to stay on therapies. The Intouch team’s strength in so many areas is a natural complement to our existing agency team at EVERSANA ENGAGE, which includes deep expertise in many areas, including market access strategy development.  

The EVERSANA model has been embraced by the industry, and we will continue to invest in people and technology that can help us further deliver on our mission and purpose of helping create a healthier world. 

What’s your one-minute elevator speech about your company? 

That’s a great question. And at EVERSANA, it’s an easy answer. At its core, here’s what I would say:  

At EVERSANA, we help our clients and partners in the life sciences and pharmaceutical industries develop the strategies and programs to successfully bring new and existing therapies to markets across the globe that will help positively impact the lives of patients. 

Patients are at the heart of all we do, and a health care decision is the most personal decision that anyone can make. We’re a diverse team – from strategists with deep knowledge of global pricing, access and adherence challenges to patient services and pharmacy experts to leaders in distribution, regulatory compliance, and even marketing.  

Today’s health care system is more connected than ever and the decisions that all stakeholders make have an immediate impact on patients’ lives. We believe that by understanding the patient journey, we can create compelling brand experiences backed by innovative solutions. We’re more than 6,000 employees across the globe who come together with a shared set of values focused on delivering on the needs of our customers and helping to transform how care is delivered through innovative new approaches leveraging the power of data and technology.